Merck & Co has reached an agreement to buy Prometheus Biosciences in a $200-per-share cash transaction that values the San Diego-based biotech at $10.8 billion. The main object of the takeover is ...
an immunology drug acquired in Davis’ $10.8 billion buyout of Prometheus Biosciences. That adds up to a potential $35 billion ...
Merck now finds itself in the same precarious ... and acquisitions like the $11 billion purchase of immunology-focused ...
Merck issued a US$6bn jumbo bond on Monday to help fund its US$10.8bn acquisition of Prometheus Biosciences that will give the pharmaceutical giant a foothold in therapies for immune diseases as it ...
Global Mesoporous Silica Market is valued at approximately USD 185.6 Million in 2022 and is anticipated to grow with a healthy growth rate of more than 9.7% over the forecast period 2023-2030.